BCLI investors rewarded by market outperformance
24 Apr, 20245 min read
BRAINSTORM CELL THERAPEUTICS INC. outperformed the broader market today. It increased by +3.81% to close at 0.545. During the last week it increased by +6.03% and saw a maximum drawdown of -2.78% before bouncing back.